Dialysis For Heart Failure? FDA Panel Urges Randomized Trials First
This article was originally published in The Gray Sheet
Executive Summary
Randomized clinical trials are needed to allow blood filtration devices to be labeled for heart failure treatment, according to FDA's gastroenterology and urology devices panel